AHG Market Analysis

News & Sentiment

50 articles · sorted by date
Page 1 of 3 · 50 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

Fundamentals

Updated daily after market close
P/E ratio
EPS (TTM)$-0.030.0% YoY
Profit margin-135.0%HEALTHCARE
Market cap$1.35BSmall cap

Valuation

Forward P/E
PEG ratio
P/B
7.43
P/S (TTM)
97.24
EV/EBITDA
-0.39

Profitability & growth

ROE (TTM)
-9.8%
Operating margin
-37.5%
Revenue growth YoY
-12.9%
Dividend yield
Beta
-1.00
Last earnings
Feb 10, 2026 · Estimate $0.00 · Reported $0.00
Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

About Akso Health Group ADR

Company profile

Akso Health Group ADR is a leading entity in the healthcare sector, dedicated to providing innovative medical solutions and comprehensive patient care services. With a strong emphasis on advanced health technologies, the company is strategically positioned in the telehealth and personalized medicine markets, supported by a robust research and development framework. As it navigates the rapidly evolving healthcare landscape, Akso Health Group presents an attractive investment opportunity for institutional investors seeking to capitalize on transformative trends within the industry.

Classification

Exchange
NASDAQ
Country
China
Currency
USD

Company profile

HQ
QIANTONGYUAN BUILDING, QINGDAO, CHINA
Fiscal year end
March
Latest quarter
Dec 31, 2025
Market cap$1.35B
Shares outstanding$854.0M
52W high$2.50
52W low$1.10

We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer